Evidence map›Paper›PMID 37396299›Full record

ArticleMediators of inflammation2023

The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing.

Pingping Hu, Yuwen Li, Wen Zhang, Rui Liu, Linya Peng, Ruirui Xu, Jinyuan Cai, Hui Yuan, Tiantong Feng, Anran Tian and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediators of inflammation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Prognostic biomarkers based onTranslational cancer research · 2024
    Article
  6. [Inhibitory effect of small-molecule compound AM679 targeting elongation-factor binding protein 2 on hepatitis B virus in vitro].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Pingping HuDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0001-6702-9615
Yuwen LiDepartment of Pediatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0009-0008-7673-3987
Wen ZhangDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0002-9474-9359
Rui LiuDepartment of Infectious and Tropical Diseases, The Second Affiliated Hospital of Hainan Medical University, Hainan, China.ORCID https://orcid.org/0000-0002-9962-6980
Linya PengDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0009-0006-0243-0583
Ruirui XuDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0002-5461-0600
Jinyuan CaiDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0009-0003-2680-4007
Hui YuanDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0001-8533-260X
Tiantong FengDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0009-0006-0673-0006
Anran TianDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0001-9008-3425
Ming YueDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0002-7677-0832
Jun LiDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0002-1961-7188
Wenting LiDepartment of Infectious and Tropical Diseases, The Second Affiliated Hospital of Hainan Medical University, Hainan, China.ORCID https://orcid.org/0000-0001-7734-4838
Chuanlong ZhuDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0001-6557-1654
Jiangsu Province Hospital · CNHainan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methods: Using a CRISPR/Cas9 gene-editing system, Results: IFN-induced anti-HBV activity was found to be restricted in Conclusion:

Indexed as

Janus KinasesSpliceosomesHepatitis B virusHep G2 CellsHumansPeptide Elongation FactorsRibonucleoprotein, U5 Small NuclearRNA, MessengerSignal TransductionSTAT Transcription FactorsVirus ReplicationEFTUD2 protein, humanJanus KinasesPeptide Elongation FactorsRibonucleoprotein, U5 Small NuclearRNA, MessengerSTAT Transcription Factors

Identifiers

PMID37396299
PMCPMC10313468
OpenAlexW4381801319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.